Pay in 4 interest-free payments of $5.04 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
On successfully completing of the course, participants will receive a certificate of attendance
The study used 0.5 mg/kg oral KPV doses and documented significant NF-B suppression in colonic tissue
Phase 1b/2 study of binimetinib (BINI) in combination with nivolumab (NIVO) or NIVO plus ipilimumab (IPI) in patients (pts) with previously treated microsatellite-stable (MSS) metastatic colorectal cancer (mCRC) with RAS mutation
For aligner labs and orthodontic practices in Mexico producing high case volumes, the faster cycle time translates to meaningful throughput gains
.png)
US$ 22.05
US$ 21.69
US$ 22.19
